| 臺大學術典藏 |
2020-11-30T06:15:24Z |
A pilot randomized controlled trial to improve geriatric frailty
|
DING-CHENG CHAN; Tsou H.-H.; Yang R.-S.; Tsauo J.-Y.; Chen C.-Y.; Hsiung C.A.; Kuo K.N. |
| 臺大學術典藏 |
2020-11-30T06:15:23Z |
A 12-year ecological study of hip fracture rates among older Taiwanese adults
|
DING-CHENG CHAN; Lee Y.-S.; Wu Y.-J.; Tsou H.-H.; Chen C.-T.; Hwang J.-S.; Tsai K.-S.; Yang R.-S. |
| 臺大學術典藏 |
2020-11-30T06:15:15Z |
Integrated care for geriatric frailty and sarcopenia: a randomized control trial
|
DING-CHENG CHAN; Tsou H.-H.; Chang C.-B.; Yang R.-S.; Tsauo J.-Y.; Chen C.-Y.; Hsiao C.-F.; Hsu Y.-T.; Chen C.-H.; Chang S.-F.; Hsiung C.A.; Kuo K.N. |
| 臺大學術典藏 |
2020-11-04T09:17:21Z |
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment
|
Wang S.-M.; Chen C.-Y.; Hsiao M.-C.; Tang H.-S.; Liu S.-I.; Chang L.-H.; CHI-SHIN WU; Tsou H.-H.; Tsai M.-H.; Liu C.-Y.; Lin K.-M.; Chiu Y.-F.; Tsai I.J.; Chen C.-H.; Shen W.W.; Liu S.C.; Lu S.-C.; Kuo H.-W.; Hsu Y.-T.; Liu Y.-L. |
| 臺大學術典藏 |
2020-11-04T09:17:20Z |
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer
|
Wang S.-C.; Ho I.-K.; Tsou H.-H.; Tian J.-N.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Lin K.-M.; Chen C.-Y.; Liu S.C.; Wu H.-Y.; Chan H.-W.; Tsai M.-H.; Lin P.-S.; Liu Y.-L. |
| 臺大學術典藏 |
2020-11-04T09:17:19Z |
UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients
|
Chen Y.-T.; Liu M.-L.; Fang C.-P.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU; Su L.-W.; Huang C.-L.; Yang Y.-H.; Tsou H.-H.; Tian J.-N.; Ho I.-K.; Liu S.C.; Hsu Y.-T.; Kuo H.-W.; Liu C.T.; Yang Y.-T.; Chen A.C.H.; Shih Y.-H.; Liu Y.-L. |
| 臺大學術典藏 |
2020-11-04T09:17:16Z |
Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort
|
Wang S.-C.; Ho I.-K.; Tsou H.-H.; Liu S.-W.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Lin K.-M.; Liu S.C.; Wu H.-Y.; Kuo H.-W.; Chen A.C.H.; Chang Y.-S.; Liu Y.-L. |
| 臺大學術典藏 |
2020-07-21T07:51:09Z |
Prediction of annual dengue incidence by hydro-climatic extremes for southern Taiwan
|
Yuan, H.-Y.; Wen, T.-H.; Kung, Y.-H.; Tsou, H.-H.; Chen, C.-H.; Chen, L.-W.; Lin, P.-S.; TZAI-HUNG WEN |
| 臺大學術典藏 |
2020-04-10T12:51:10Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Chiun Hsu; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:03Z |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chen L.-T.; Huang S.-F.; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Chiun Hsu; Chiang N.-J.; Chiang N.-J.;Chiun Hsu;Chen J.-S.;Tsou H.-H.;Shen Y.-Y.;Chao Y.;Chen M.-H.;Yeh T.-S.;Shan Y.-S.;Huang S.-F.;Chen L.-T. |
| 臺大學術典藏 |
2020-04-10T12:51:00Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
Taiwan Cooperative Oncology Group; Chiun Hsu; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; Chen P.-J.; Cheng A.-L.; Tsou H.-H.; Yang H.-C.; Yang H.-C.;Tsou H.-H.;Pei S.-N.;Chang C.-S.;Chen J.-H.;Yao M.;Lin S.-J.;Lin J.;Yuan Q.;Xia N.;Liu T.-W.;Chen P.-J.;Cheng A.-L.;Chiun Hsu;Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2020-04-10T12:50:59Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.;Yang H.-C.;Hsiao C.-F.;Hsiung C.A.;Liu T.-W.;Chuang M.-H.;Wu H.-Y.;Hsu Y.-T.;Tsui C.-W.;Chen P.-J.;Cheng A.-L.;Chiun Hsu;Taiwan Cooperative Oncology Group; Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; Cheng A.-L.; Chiun Hsu; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2020-02-06T08:11:29Z |
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
|
Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Shen W.W.; Tang H.-S.; Fang C.-K.; Wu C.-S.; SHAO-CHUN LU; Kuo H.-W.; Liu S.C.; Chan H.-W.; Hsu Y.-T.; Tian J.-N.; Liu Y.-L.; Lin K.-M.;Tsou H.-H.;Tsai I.-J.;Hsiao M.-C.;Hsiao C.-F.;Liu C.-Y.;Shen W.W.;Tang H.-S.;Fang C.-K.;Wu C.-S.;Shao-Chun Lu;Kuo H.-W.;Liu S.C.;Chan H.-W.;Hsu Y.-T.;Tian J.-N.;Liu Y.-L.; Lin K.-M.; Tsou H.-H.; Tsai I.-J. |
| 臺大學術典藏 |
2020-02-06T08:11:28Z |
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
|
Kuo H.-W.;Liu S.C.;Tsou H.-H.;Liu S.-W.;Lin K.-M.;Shao-Chun Lu;Hsiao M.-C.;Hsiao C.-F.;Liu C.-Y.;Chen C.-H.;Lu M.-L.;Shen W.W.;Tang H.-S.;Liu S.-I.;Chang L.-H.;Wu H.-Y.;Chang Y.-S.;Yeh T.-K.;Chen A.C.;Liu Y.-L.; Kuo H.-W.; Liu S.C.; Tsou H.-H.; Liu S.-W.; Lin K.-M.; SHAO-CHUN LU; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Chen C.-H.; Lu M.-L.; Shen W.W.; Tang H.-S.; Liu S.-I.; Chang L.-H.; Wu H.-Y.; Chang Y.-S.; Yeh T.-K.; Chen A.C.; Liu Y.-L. |
| 臺大學術典藏 |
2020-02-06T08:11:28Z |
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment
|
Lin K.-M.; Chiu Y.-F.; Tsai I.J.; Chen C.-H.; Shen W.W.; Liu S.C.; SHAO-CHUN LU; Liu C.-Y.; Hsiao M.-C.; Tang H.-S.; Liu S.-I.; Chang L.-H.; Wu C.-S.; Tsou H.-H.; Tsai M.-H.; Chen C.-Y.; Wang S.-M.; Kuo H.-W.; Hsu Y.-T.; Liu Y.-L.; Lin K.-M.;Chiu Y.-F.;Tsai I.J.;Chen C.-H.;Shen W.W.;Liu S.C.;Shao-Chun Lu;Liu C.-Y.;Hsiao M.-C.;Tang H.-S.;Liu S.-I.;Chang L.-H.;Wu C.-S.;Tsou H.-H.;Tsai M.-H.;Chen C.-Y.;Wang S.-M.;Kuo H.-W.;Hsu Y.-T.;Liu Y.-L. |
| 臺大學術典藏 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Tsou H.-H.; CHIUN HSU; Yen C.-J.; Yang S.-H.; Chen M.-H.; Chiang N.-J. |
| 國立成功大學 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang, N.-J.;Chen, M.-H.;Yang, S.-H.;Hsu, C.;Yen, C.-J.;Tsou, H.-H.;Su, Y.-Y.;Chen, J.-S.;Shan, Y.-S.;Chen, L.-T. |
| 臺大學術典藏 |
2018-09-10T08:37:09Z |
A consistency approach to evaluation of bridging studies and multi-regional trials
|
Tsou, H.-H.;Chien, T.-Y.;Liu, J.-P.;Hsiao, C.-F.; Tsou, H.-H.; Chien, T.-Y.; Liu, J.-P.; Hsiao, C.-F.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T08:10:20Z |
Sample size determination for a specific region in a multiregional trial
|
Ko, F.-S.;Tsou, H.-H.;Liu, J.-P.;Hsiao, C.-F.; Ko, F.-S.; Tsou, H.-H.; Liu, J.-P.; Hsiao, C.-F.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:24:51Z |
Use of prior information for Bayesian evaluation of bridging studies
|
|JEN-PEI LIU; Hsiao, C.-F.;Hsu, Y.-Y.;Tsou, H.-H.;Liu, J.-P.; Hsiao, C.-F.; Hsu, Y.-Y.; Tsou, H.-H.; Liu, J.-P. |
| 國立成功大學 |
2015-05-01 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, J. S.; Hsu, C.; Chiang, N. J.; Tsai, C. S.; Tsou, H. H.; Huang, S. F.; Bai, L. Y.; Chang, I. C.; Shiah, H. S.; Ho, C. L.; Yen, C. J.; Lee, K. D.; Chiu, C. F.; Rau, K. M.; Yu, M. S.; Yang, Y.; Hsieh, R. K.; Chang, J. Y.; Shan, Y. S.; Chao, Y.; Chen, L. T. |
| 國立臺灣大學 |
2015 |
LONG-TERM OUTCOME OF CHEMOTHERAPY-INDUCED HBV REACTIVATION IN LYMPHOMA PATIENTS WITH RESOLVED HBV INFECTION
|
Yang, H. -C.; Tsou, H. -H.; Chuang, M. -H.; Chen, C. -L.; Liu, T. -W.; Chen, P. -J.; Cheng, A. -L.; Hsu, C.; 鄭安理; 許駿; 陳培哲; 陳祈玲 |
| 臺大學術典藏 |
2015 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
on behalf of the Taiwan Cooperative Oncology Group; Wei T.-C.; Shan Y.S.; Chao Y.; Chen L.-T.; Chin Y.-H.; Chung T.-R.; Yu W.-L.; Lee M.-H.; Lin L.-F.; Lin P.-C.; Wu Y.-L.; Wang H.-L.; Lu L.-J.; Chen S.-Y.; Wu C.-C.; Chang J.Y.; Yu M.S.; Yang Y.; Hsieh R.K.; Chiu C.F.; Rau K.M.; Lee K.D.; Shiah H.S.; Chang I.C.; Bai L.Y.; Huang S.F.; Tsou H.H.; Tsai C.S.; Chiang N.J.; CHIH-HUNG HSU; Chen J.S.; Chen J.S.;Chih-Hung Hsu;Chiang N.J.;Tsai C.S.;Tsou H.H.;Huang S.F.;Bai L.Y.;Chang I.C.;Shiah H.S.;Ho C.L.;Yen C.J.;Lee K.D.;Chiu C.F.;Rau K.M.;Yu M.S.;Yang Y.;Hsieh R.K.;Chang J.Y.;Shan Y.S.;Chao Y.;Chen L.-T.;Chin Y.-H.;Chung T.-R.;Yu W.-L.;Lee M.-H.;Lin L.-F.;Lin P.-C.;Wu Y.-L.;Wang H.-L.;Lu L.-J.;Chen S.-Y.;Wu C.-C.;Wei T.-C.;On Behalf Of The Taiwan Cooperative Oncology Group; Yen C.J.; Ho C.L. |
| 國立臺灣大學 |
2014 |
PREVENTION OF CHEMOTHERAPY-INDUCED HBV-RELATED HEPATITIS FLARE IN LYMPHOMA PATIENTS WITH RESOLVED HBV INFECTION: COST ANALYSIS
|
Tsou, H. -H.; Yang, H. -C.; Chuang, M. -H.; Wu, H. -Y.; Hsu, Y. -T.; Chang, W. -J.; Hsiao, C. -F.; Hsu, C.; 許駿 |
| 臺大學術典藏 |
2014 |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Wang M.-C.; Lin S.-J.; Tsou H.-H.; Hsu C.; Cheng A.-L.; Liu T.-W.; Chen P.-J.; HWEI-FANG TIEN; Chang C.-S.; Lin J.; Lin S.-F.; Chiu C.-F.; Kao W.-Y.; Yao M.; Hwang W.-L. |
